GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
---|
CD44 | 1681 | LTM | Gastric Cancer | Carcinoma | KATO-III | NA | SFA followed by Western Blotting and IF staining | NA | 0.52 | 1 | 33288885
|
CD44 | 1681 | LTM | Gastric Cancer | Carcinoma | KATO-III | NA | SFA followed by Western Blotting | NA | 0.52 | 1 | 32606358
|
CD44 | 1681 | LTM | Gastric Cancer | Carcinoma | KATO-III | NA | FACs | NA | 0.52 | 1 | 30485589
|
CD44 | 1681 | LTM | Gastric Cancer | Carcinoma | KATO-III | NA | FACs | NA | 0.52 | 1 | 19415765
|
SOX2 | 11195 | LTM | Gastric Cancer | Carcinoma | KATO-III | NA | SFA followed by Western Blotting and IF staining | NA | 0.52 | 0.5695 | 33288885
|
SOX2 | 11195 | LTM | Gastric Cancer | Carcinoma | KATO-III | NA | qRT-PCR followed by Western Blotting | NA | 0.52 | 0.5695 | 32093282
|
SOX2 | 11195 | LTM | Gastric Cancer | Carcinoma | KATO-III | NA | SFA followed by Western Blotting | NA | 0.52 | 0.5695 | 32606358
|
DLL4 | 2910 | LTM | Gastric Cancer | Carcinoma | KATO-III | NA | Western Blotting followed by CFA | NA | 0.28 | 0.0042 | 27891816
|
MYC | 7553 | LTM | Gastric Cancer | Carcinoma | KATO-III | NA | SFA followed by Western Blotting | NA | 0.28 | 0.1304 | 32606358
|
MYC | 7553 | LTM | Gastric Cancer | Carcinoma | KATO-III | NA | SFA followed by Western Blotting | NA | 0.28 | 0.1304 | 33288885
|
NANOG | 20857 | LTM | Gastric Cancer | Carcinoma | KATO-III | NA | SFA followed by Western Blotting | NA | 0.28 | 0.5461 | 32606358
|
NANOG | 20857 | LTM | Gastric Cancer | Carcinoma | KATO-III | NA | SFA followed by Western Blotting | NA | 0.28 | 0.5461 | 33288885
|
NANOG | 20857 | LTM | Gastric Cancer | Carcinoma | KATO-III | NA | SFA followed by qRT-PCR | NA | 0.28 | 0.5461 | 31233198
|
POU5F1 | 9221 | LTM | Gastric Cancer | Carcinoma | KATO-III | NA | SFA followed by Western Blotting | NA | 0.28 | 0.6448 | 32606358
|
POU5F1 | 9221 | LTM | Gastric Cancer | Carcinoma | KATO-III | NA | SFA followed by Western Blotting | NA | 0.28 | 0.6448 | 33288885
|
POU5F1 | 9221 | LTM | Gastric Cancer | Carcinoma | KATO-III | NA | SFA followed by qRT-PCR | NA | 0.28 | 0.6448 | 31233198
|
TBL1XR1 | 29529 | LTM | Gastric Cancer | Carcinoma | KATO-III | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0011 | 33288885
|
CXCR4 | 2561 | LTM | Gastric Cancer | Carcinoma | KATO-III | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0498 | 31233198
|
EPCAM | 11529 | LTM | Gastric Cancer | Carcinoma | KATO-III | NA | qRT-PCR and SFA | NA | 0.2 | 0.211 | 31233198
|
MIR193A | 31563 | LTM | Gastric Cancer | Carcinoma | KATO-III | NA | FACs for CSC marker followed by RT-PCR | NA | 0.2 | 0.0042 | 30485589
|
NES | 7756 | LTM | Gastric Cancer | Carcinoma | KATO-III | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0573 | 31233198
|
NES | 7756 | LTM | Gastric Cancer | Carcinoma | KATO-III | NA | FACs followed by CFA | NA | 0.2 | 0.0573 | 27891816
|
THY1 | 11801 | LTM | Gastric Cancer | Carcinoma | KATO-III | NA | qRT-PCR and SFA | NA | 0.2 | 0.0371 | 31233198
|
ALCAM | 400 | LTM | Gastric Cancer | Carcinoma | KATO-III | NA | FACs | NA | 0.12 | 0.0583 | 19415765
|
CD24 | 1645 | LTM | Gastric Cancer | Carcinoma | KATO-III | NA | FACs | NA | 0.12 | 0.456 | 19415765
|
FIT3 | NA | LTM | Gastric Cancer | Carcinoma | KATO-III | NA | FACs | NA | 0.12 | 0.0011 | 19415765
|
FUT4 | 4015 | LTM | Gastric Cancer | Carcinoma | KATO-III | NA | FACs | NA | 0.12 | 0.0085 | 19415765
|
LGR5 | 4504 | LTM | Gastric Cancer | Carcinoma | KATO-III | NA | FACs followed by CFA | NA | 0.12 | 0.0753 | 27891816
|
PROM1 | 9454 | LTM | Gastric Cancer | Carcinoma | KATO-III | NA | FACs | NA | 0.12 | 0.7582 | 19415765
|